Insomnia linked with Alzheimer's biomarkers; Oxford Gene Technology has licensed new cancer biomarkers;

> Oxford Gene Technology has licensed 12 colorectal cancer biomarkers from Inven2, the technology transfer office at Oslo University Hospital and University of Oslo. Press release

> Trouble sleeping? There are links between insomnia and Alzheimer's disease biomarkers, according to the AAN Annual Meeting. Abstract

> Epigenomics' Septin9 biomarker test detects colon cancer on both the right and left sides of the colon. Press release

> Indian and U.S. researchers are collaborating to develop a "Ureome Database" for oncology research. Press release

> VTT is involved in an EU project, DEXLIFE, looking at preventing Type 2 diabetes by finding diagnostic and predictive biomarkers. Press release

> FirstMark's PREvent MI blood-based biomarker test has completed its clinical trial. Press release

> Researchers have found a possible predictive biomarker for everolimus in gastric cancer. Abstract

> HealthLinx has validated an ovarian cancer biomarker that could predict disease outcomes. Article

> ColonSentry, a blood-based biomarker test for colorectal cancer, has been approved for market by the New York State Department of Health. Press release

> The U.K. biomarker validation company Abcodia and life sciences company VolitionRx have announced a collaboration to work on biomarkers for the early detection of cancer. Article

And Finally… A new round Mesothelioma Applied Research Foundation funding is going toward 5 projects, including biomarker projects. Press release

Suggested Articles

The ADDF announced its second round of research awards, with a total of $6 million in new funding for diagnostic tests.

Takeda teamed up with Enzyre to develop an at-home diagnostic device that will help people with hemophilia determine their own coagulation status.

Foundation Medicine received a diagnostic approval from the FDA for selecting HR+/HER2- breast cancer patients for treatment with Novartis' Piqray.